Drugs / L-CsA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01439958 | Feb 2012 → Jul 2013 | transplant-related bronchiolitis obliterans | Pari Pharma GmbH | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | L-CsA | “A Long-term Safety Follow-up Study of L-CsA Therapy for Patients Who Participated in Study 12011.201 and Volunteered to Continue or to Cross-over to L-CsA Inhalation Therapy” NCT01439958 ↗ |
| Route | Inhaled | “Twice daily inhalation for a maximum of three years.” NCT01439958 ↗ |